Cargando…
High expression of TAZ indicates a poor prognosis in retinoblastoma
BACKGROUND: The transcriptional co-activator, TAZ, is an important effector of the Hippo pathway and is critical for the development of human cancers. However, the expression and prognostic significance of TAZ in retinoblastoma is currently unclear. METHODS: TAZ expression was examined in 43 retinob...
Autores principales: | Zhang, Yiting, Xue, Chunyan, Cui, Hongjuan, Huang, Zhenping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605227/ https://www.ncbi.nlm.nih.gov/pubmed/26464030 http://dx.doi.org/10.1186/s13000-015-0415-9 |
Ejemplares similares
-
TAZ Expression as a Prognostic Indicator in Colorectal Cancer
por: Yuen, Hiu-Fung, et al.
Publicado: (2013) -
Correction: TAZ Expression as a Prognostic Indicator in Colorectal Cancer
por: Yuen, Hiu-Fung, et al.
Publicado: (2021) -
Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma
por: Gao, Yali, et al.
Publicado: (2017) -
High expression of cluster of differentiation 276 indicates poor prognosis in glioma
por: Li, Linchen, et al.
Publicado: (2021) -
High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)